PICTON MAHONEY ASSET MANAGEMENT
Position in SLXN — Silexion Therapeutics Corp
CIK 1539041
Toronto, A6
Position in SLXN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$0
+$0 QoQ
Shares Held
57,175
0.0% QoQ
Ownership
1.03%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SLXN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PICTON MAHONEY ASSET MANAGEMENT holds $71,124,535 across 23 Biotechnology names. SLXN ranks #23 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | 165,000 | $21,900,450 | |||
| 2 | QURE |
uniQure N.V.
|
181,215 | $8,346,762 | |
| 3 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
65,880 | $7,314,656 | |
| 4 | ZYME |
Zymeworks Inc.
|
271,343 | $7,092,906 | |
| 5 | MIRM |
Mirum Pharmaceuticals, Inc.
|
47,679 | $5,581,780 | |
| 6 | CAI |
Caris Life Sciences, Inc.
|
264,064 | $4,705,620 | |
| 7 | CGON |
CG Oncology, Inc.
|
63,867 | $4,537,750 | |
| 8 | ABVX |
Abivax S.A.
|
27,712 | $3,692,901 |
No Holdings History
No holdings records found for this institution in SLXN.